Portal de investigación
Identification of NLRP3(PYD) Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity
Fecha de publicación:
Autores de CIPF
Participantes ajenos a CIPF
- Ghafary, SM
- Lotfollahzadeh, S
- Serrano-Candelas, E
- Karami, F
- Barigye, SJ
- Fernandez-Perez, I
- Gozalbes, R
- Nikkhah, M
- Hosseinkhani, S
Grupos de Investigación
Abstract
Inflammasomes are multiprotein complexes that represent critical elements of the inflammatory response. The dysregulation of the best-characterized complex, the NLRP3 inflammasome, has been linked to the pathogenesis of diseases such as multiple sclerosis, type 2 diabetes mellitus, Alzheimer's disease, and cancer. While there exist molecular inhibitors specific for the various components of inflammasome complexes, no currently reported inhibitors specifically target NLRP3(PYD) homo-oligomerization. In the present study, we describe the identification of QM380 and QM381 as NLRP3(PYD) homo-oligomerization inhibitors after screening small molecules from the MyriaScreen library using a split-luciferase complementation assay. Our results demonstrate that these NLRP3(PYD) inhibitors interfere with ASC speck formation, inhibit pro-inflammatory cytokine IL1-beta release, and decrease pyroptotic cell death. We employed spectroscopic techniques and computational docking analyses with QM380 and QM381 and the PYD domain to confirm the experimental results and predict possible mechanisms underlying the inhibition of NLRP3(PYD) homo-interactions.
Datos de la publicación
- ISSN/ISSNe:
- 1422-0067, 1422-0067
- Tipo:
- Article
- Páginas:
- -
- DOI:
- 10.3390/ijms23031651
- PubMed:
- 35163573
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES MDPI
Citas Recibidas en Web of Science: 16
Documentos
- No hay documentos
Filiaciones
Keywords
- inflammasome inhibitors; NLRP3; PYD; screening; split-luciferase; pyroptosis
Financiación
Proyectos asociados
Ensuring long-term sustainability of excellence in chemical biology within Europe and beyond
Investigador Principal: MARIA JESUS VICENT DOCON
COMMISSION OF EUROPEAN COMMUNITIES . 2019
MEMBDEATH: Muerte celular y membranas: un nuevo nicho en la lucha contra el cáncer. Colab con la UV, no recibimos financiación
Investigador Principal: MARIA MAR ORZÁEZ CALATAYUD
CONSELLERIA DE EDUCACION . 2019
El interactoma de membrana de las proteínas de la familia Bcl-2 como diana antitumoral
Investigador Principal: MARIA MAR ORZÁEZ CALATAYUD
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2021
VALORIZATION OF A FIRST-IN-CLASS MCL-1 INHIBITOR
Investigador Principal: MARIA MAR ORZÁEZ CALATAYUD
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2021